Magnitude of the placebo effect in randomized trials of antiepileptic agents

Jorge G. Burneo, Victor Manuel Montori, Edward Faught

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Placebo-controlled randomized trials ideally produce unbiased estimates of the treatment effect after accounting for nonpharmacological effects (regression to the mean, Hawthorne, and placebo effects). Recognizing that the magnitude of these effects may help understand why investigators need to control for them, we sought to measure this magnitude. We reviewed published meta-analyses of randomized, placebo-controlled add-on trials of antiepileptic medications versus placebo, included in the Cochrane Library. In randomized trials of antiepileptic agents for epilepsy, 9.3-16.6% of patients in the placebo arm had a >50% reduction in seizure frequency. This effect represents 20-50% of the effect observed with active agents. Because patients with epilepsy in the placebo arm of randomized trials experience a large clinical benefit due to non pharmacological effects, randomized controlled trials are necessary to gauge the true magnitude of the treatment effect of new antiepileptic agents.

Original languageEnglish (US)
Pages (from-to)532-534
Number of pages3
JournalEpilepsy and Behavior
Volume3
Issue number6
DOIs
StatePublished - Dec 2002

Fingerprint

Placebo Effect
Anticonvulsants
Placebos
Epilepsy
Randomized Controlled Trials
Epidemiologic Effect Modifiers
Libraries
Meta-Analysis
Seizures
Research Personnel
Pharmacology
Therapeutics

Keywords

  • Antiepileptic agents
  • Epilepsy
  • Placebo
  • Randomized trials

ASJC Scopus subject areas

  • Clinical Neurology
  • Behavioral Neuroscience
  • Neurology

Cite this

Magnitude of the placebo effect in randomized trials of antiepileptic agents. / Burneo, Jorge G.; Montori, Victor Manuel; Faught, Edward.

In: Epilepsy and Behavior, Vol. 3, No. 6, 12.2002, p. 532-534.

Research output: Contribution to journalArticle

@article{9d5496a9678742158107a0bfff85b350,
title = "Magnitude of the placebo effect in randomized trials of antiepileptic agents",
abstract = "Placebo-controlled randomized trials ideally produce unbiased estimates of the treatment effect after accounting for nonpharmacological effects (regression to the mean, Hawthorne, and placebo effects). Recognizing that the magnitude of these effects may help understand why investigators need to control for them, we sought to measure this magnitude. We reviewed published meta-analyses of randomized, placebo-controlled add-on trials of antiepileptic medications versus placebo, included in the Cochrane Library. In randomized trials of antiepileptic agents for epilepsy, 9.3-16.6{\%} of patients in the placebo arm had a >50{\%} reduction in seizure frequency. This effect represents 20-50{\%} of the effect observed with active agents. Because patients with epilepsy in the placebo arm of randomized trials experience a large clinical benefit due to non pharmacological effects, randomized controlled trials are necessary to gauge the true magnitude of the treatment effect of new antiepileptic agents.",
keywords = "Antiepileptic agents, Epilepsy, Placebo, Randomized trials",
author = "Burneo, {Jorge G.} and Montori, {Victor Manuel} and Edward Faught",
year = "2002",
month = "12",
doi = "10.1016/S1525-5050(02)00531-0",
language = "English (US)",
volume = "3",
pages = "532--534",
journal = "Epilepsy and Behavior",
issn = "1525-5050",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Magnitude of the placebo effect in randomized trials of antiepileptic agents

AU - Burneo, Jorge G.

AU - Montori, Victor Manuel

AU - Faught, Edward

PY - 2002/12

Y1 - 2002/12

N2 - Placebo-controlled randomized trials ideally produce unbiased estimates of the treatment effect after accounting for nonpharmacological effects (regression to the mean, Hawthorne, and placebo effects). Recognizing that the magnitude of these effects may help understand why investigators need to control for them, we sought to measure this magnitude. We reviewed published meta-analyses of randomized, placebo-controlled add-on trials of antiepileptic medications versus placebo, included in the Cochrane Library. In randomized trials of antiepileptic agents for epilepsy, 9.3-16.6% of patients in the placebo arm had a >50% reduction in seizure frequency. This effect represents 20-50% of the effect observed with active agents. Because patients with epilepsy in the placebo arm of randomized trials experience a large clinical benefit due to non pharmacological effects, randomized controlled trials are necessary to gauge the true magnitude of the treatment effect of new antiepileptic agents.

AB - Placebo-controlled randomized trials ideally produce unbiased estimates of the treatment effect after accounting for nonpharmacological effects (regression to the mean, Hawthorne, and placebo effects). Recognizing that the magnitude of these effects may help understand why investigators need to control for them, we sought to measure this magnitude. We reviewed published meta-analyses of randomized, placebo-controlled add-on trials of antiepileptic medications versus placebo, included in the Cochrane Library. In randomized trials of antiepileptic agents for epilepsy, 9.3-16.6% of patients in the placebo arm had a >50% reduction in seizure frequency. This effect represents 20-50% of the effect observed with active agents. Because patients with epilepsy in the placebo arm of randomized trials experience a large clinical benefit due to non pharmacological effects, randomized controlled trials are necessary to gauge the true magnitude of the treatment effect of new antiepileptic agents.

KW - Antiepileptic agents

KW - Epilepsy

KW - Placebo

KW - Randomized trials

UR - http://www.scopus.com/inward/record.url?scp=0038823449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038823449&partnerID=8YFLogxK

U2 - 10.1016/S1525-5050(02)00531-0

DO - 10.1016/S1525-5050(02)00531-0

M3 - Article

AN - SCOPUS:0038823449

VL - 3

SP - 532

EP - 534

JO - Epilepsy and Behavior

JF - Epilepsy and Behavior

SN - 1525-5050

IS - 6

ER -